Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. (Q51509683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

title

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Dominique Turck

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Valérie Crombé

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Julia Salleron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Guillaume Savoye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Jean-Louis Dupas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Gwénola Vernier-Massouille

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Eric Lerebours

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Véronique Merle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Francis Vasseur

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Corinne Gower-Rousseau

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Marc Lémann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Alain Duhamel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

Jean-Frédéric Colombel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

2144-2152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287665 AND SRC:MED&resulttype=core&format=json

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2020

cites work

1 reference

Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence

21 January 2018

1 reference

Inflammatory bowel diseases in children

21 January 2018

1 reference

Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).

21 January 2018

1 reference

Natural history of pediatric Crohn's disease: a population-based cohort study

21 January 2018

1 reference

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

21 January 2018

1 reference

Use of infliximab in the treatment of Crohn's disease in children and adolescents

21 January 2018

1 reference

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

21 January 2018

1 reference

A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease.

21 January 2018

1 reference

Incidence of inflammatory bowel disease in northern France (1988-1990).

21 January 2018

1 reference

Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999)

21 January 2018

1 reference

Smoothing reference centile curves: the LMS method and penalized likelihood

21 January 2018

1 reference

Cross sectional stature and weight reference curves for the UK, 1990

21 January 2018

1 reference

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

21 January 2018

1 reference

Use of infliximab in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

21 January 2018

1 reference

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands

21 January 2018

1 reference

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

21 January 2018

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

21 January 2018

1 reference

Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.

21 January 2018

1 reference

Guidelines for the management of growth failure in childhood inflammatory bowel disease

21 January 2018

1 reference

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease

21 January 2018

1 reference

Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients

21 January 2018

1 reference

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

21 January 2018

1 reference

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference